Skip to content

PARC ELISABETH PHARMA: what changed

What changed

PARC ELISABETH PHARMA

BE 0578.934.701
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€12,285
2024 · -€3,024-€9,261
Equity
-€63,400
2024 · -€51,115-€12,285
Cash
€78
2024 · €4,334-€4,256
Balance sheet total
€296,304
2024 · €380,023-€83,719

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€45,281

    down €45,281 (-16.7%), from €271,942 to €226,661

  • Receivables within one year -€31,056

    down €31,056 (-73.8%), from €42,056 to €11,000

    of which Trade receivables: -€42,056

  • Cash -€4,256

    down €4,256 (-98.2%), from €4,334 to €78

    mainly Debts after one year (-€45,000) and Trade debts (-€26,905)

Equity and liabilities
  • Debts after one year -€45,000

    down €45,000 (-22.5%), from €199,859 to €154,859

  • Trade debts -€26,905

    down €26,905 (-36.6%), from €73,533 to €46,627

  • Profit (loss) carried forward -€12,285

    down €12,285 (-20.8%), from -€59,175 to -€71,460

  • Short-term financial debts +€9,853

    up €9,853 (+185%), from €5,326 to €15,179

  • Tax, wage and social debts -€9,748

    down €9,748 (-48.3%), from €20,199 to €10,451

Income statement
  • Turnover +€491,912

    new in 2025: €491,912

  • Purchases and services +€450,533

    new in 2025: €450,533

  • Gross operating margin -€27,871

    down €27,871 (-40.1%), from €69,418 to €41,547

  • Taxes -€15,522

    no longer reported in 2025 (was €15,522)

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€3,024
Gross operating margin -€27,871
Staff costs -€422
Depreciation -€77
Other operating charges +€122
Financial charges +€3,464
Taxes +€15,522
Result 2025 -€12,285
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€31,362
Investment €0
Financing -€35,619
Cash 2024 €4,334
Net result for the year -€12,285
Depreciation +€46,289
Stocks and contracts +€1,697
Receivables within one year +€31,056
Deferred charges and accrued income +€420
Trade debts -€26,905
Tax, wage and social debts -€9,748
Other debts +€2,995
Accrued charges and deferred income -€2,157
Debts after one year -€45,000
Current portion of long-term debt -€471
Short-term financial debts +€9,853
Cash 2025 €78
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €380,023 €296,304 -€83,719 -22.0%
Fixed assets 21/28 €276,391 €230,101 -€46,289 -16.7%
Intangible fixed assets 21 €271,942 €226,661 -€45,281 -16.7%
Tangible fixed assets 22/27 €4,108 €3,100 -€1,008 -24.5%
Plant, machinery and equipment 23 €4,108 - -€4,108
Furniture and vehicles 24 - €3,100 +€3,100
Financial fixed assets 28 €340 €340 = 0.0%
Current assets 29/58 €103,632 €66,202 -€37,430 -36.1%
Stocks and contracts in progress 3 €56,822 €55,125 -€1,697 -3.0%
Stocks 30/36 €56,822 €55,125 -€1,697 -3.0%
Amounts receivable within one year 40/41 €42,056 €11,000 -€31,056 -73.8%
Trade receivables 40 €42,056 - -€42,056
Other amounts receivable 41 - €11,000 +€11,000
Cash at bank and in hand 54/58 €4,334 €78 -€4,256 -98.2%
Deferred charges and accrued income 490/1 €420 - -€420
Total equity and liabilities 10/49 €380,023 €296,304 -€83,719 -22.0%
Equity 10/15 -€51,115 -€63,400 -€12,285 -24.0%
Contributions 10/11 €6,200 €6,200 = 0.0%
Contributions outside capital 11 - €6,200 +€6,200
Other 1109/19 - €6,200 +€6,200
Reserves 13 €1,860 €1,860 = 0.0%
Distributable reserves 133 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 -€59,175 -€71,460 -€12,285 -20.8%
Amounts payable 17/49 €431,138 €359,704 -€71,434 -16.6%
Amounts payable after more than one year 17 €199,859 €154,859 -€45,000 -22.5%
Financial debts 170/4 €199,859 €154,859 -€45,000 -22.5%
Amounts payable within one year 42/48 €229,122 €204,845 -€24,277 -10.6%
Current portion of amounts payable after more than one year 42 €45,471 €45,000 -€471 -1.0%
Financial debts 43 €5,326 €15,179 +€9,853 +185%
Credit institutions 430/8 €5,326 €15,179 +€9,853 +185%
Trade debts 44 €73,533 €46,627 -€26,905 -36.6%
Suppliers 440/4 €73,533 €46,627 -€26,905 -36.6%
Taxes, remuneration and social security 45 €20,199 €10,451 -€9,748 -48.3%
Taxes 450/3 €20,199 €10,451 -€9,748 -48.3%
Other amounts payable 47/48 €84,593 €87,588 +€2,995 +3.5%
Accrued charges and deferred income 492/3 €2,157 - -€2,157
Turnover 70 - €491,912 +€491,912
Goods, raw materials, services and sundry goods 60/61 - €450,533 +€450,533
Remuneration, social security and pensions 62 - €422 +€422
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €46,212 €46,289 +€77 +0.2%
Other operating charges 640/8 €522 €400 -€122 -23.4%
Gross operating margin 9900 €69,418 €41,547 -€27,871 -40.1%
Operating profit (loss) 9901 €22,684 -€5,563 -€28,247
Financial charges 65/66B €10,186 €6,722 -€3,464 -34.0%
Recurring financial charges 65 €10,186 €6,722 -€3,464 -34.0%
Profit (loss) for the period before taxes 9903 €12,498 -€12,285 -€24,783
Income taxes 67/77 €15,522 - -€15,522
Profit (loss) for the period 9904 -€3,024 -€12,285 -€9,261 -306%
Profit (loss) for the period to be appropriated 9905 -€3,024 -€12,285 -€9,261 -306%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.